A detailed history of Goldman Sachs Group Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 272,631 shares of ORGO stock, worth $866,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
272,631
Previous 247,950 9.95%
Holding current value
$866,966
Previous $694,000 12.25%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.42 - $3.24 $59,728 - $79,966
24,681 Added 9.95%
272,631 $779,000
Q2 2024

Aug 13, 2024

BUY
$2.28 - $3.03 $139,269 - $185,081
61,083 Added 32.69%
247,950 $694,000
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $44,711 - $76,918
-17,131 Reduced 8.4%
186,867 $530,000
Q4 2023

Feb 13, 2024

SELL
$1.97 - $4.21 $133,871 - $286,090
-67,955 Reduced 24.99%
203,998 $834,000
Q3 2023

May 14, 2024

BUY
$2.34 - $4.43 $159,014 - $301,040
67,955 Added 33.31%
271,953 $864,000
Q3 2023

Nov 14, 2023

BUY
$2.34 - $4.43 $130,939 - $247,889
55,957 Added 25.91%
271,953 $864,000
Q2 2023

May 14, 2024

SELL
$1.9 - $4.3 $757,317 - $1.71 Million
-398,588 Reduced 64.85%
215,996 $717,000
Q2 2023

Aug 14, 2023

SELL
$1.9 - $4.3 $757,317 - $1.71 Million
-398,588 Reduced 64.85%
215,996 $717,000
Q1 2023

May 14, 2024

SELL
$1.89 - $2.93 $304,418 - $471,929
-161,068 Reduced 20.77%
614,584 $1.31 Million
Q1 2023

May 11, 2023

SELL
$1.89 - $2.93 $304,418 - $471,929
-161,068 Reduced 20.77%
614,584 $1.31 Million
Q4 2022

May 14, 2024

SELL
$2.48 - $3.43 $474,781 - $656,652
-191,444 Reduced 19.8%
775,652 $2.09 Million
Q4 2022

Feb 13, 2023

SELL
$2.48 - $3.43 $474,781 - $656,652
-191,444 Reduced 19.8%
775,652 $2.09 Million
Q3 2022

May 14, 2024

SELL
$3.14 - $6.43 $255,015 - $522,212
-81,215 Reduced 7.75%
967,096 $3.13 Million
Q3 2022

Nov 10, 2022

SELL
$3.14 - $6.43 $255,015 - $522,212
-81,215 Reduced 7.75%
967,096 $3.13 Million
Q2 2022

May 14, 2024

BUY
$4.74 - $8.15 $4 Million - $6.88 Million
844,313 Added 413.88%
1,048,311 $5.12 Million
Q2 2022

Aug 15, 2022

BUY
$4.74 - $8.15 $591,670 - $1.02 Million
124,825 Added 13.52%
1,048,311 $5.12 Million
Q1 2022

May 16, 2022

BUY
$6.47 - $9.57 $589,695 - $872,238
91,143 Added 10.95%
923,486 $7.04 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $728,906 - $1.09 Million
80,810 Added 10.75%
832,343 $7.69 Million
Q3 2021

Nov 10, 2021

BUY
$13.71 - $17.18 $10.3 Million - $12.9 Million
751,533 New
751,533 $10.7 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $416M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.